Adolescent suicide and SSRI antidepressants

Australasian Psychiatry

Volumn 18, Issue 6, 2010, Pages 587-

  Haliburn, Joan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; CHILD PSYCHIATRY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; FUNCTIONAL DISEASE; HUMAN; LETTER; MENTAL DISEASE; MORBIDITY; PRESCRIPTION; PREVALENCE; PSYCHOSOCIAL CARE; RISK BENEFIT ANALYSIS; RISK REDUCTION; SUICIDE;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; HUMANS; SEROTONIN UPTAKE INHIBITORS; SUICIDE;

EID: 78649855691     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.3109/10398562.2010.502574     Document Type: Letter

References (6)

1. Dudley M, Goldney R, Hadzi-Pavlovic. Are adolescents dying by suicide taking SSRI antidepressants? A review of observational studies. Australasian Psychiatry 2010;18:242-245.
2. Jureidini JN, Doecke CJ, Mansfield PR et al. Efficacy and safety of antidepressants for children and adolescents. British Medical Journal 2004;328:879-883.
3. Kessler RC, Avenerol S, Ries Merkanges K. Mood disorders in children and adolescents: an epidemiological perspective. Biological Psychiatry 2001;49:1002-1014.
4. Weismann MM, Wolk S, Goldstein RB. Depressed adolescents grown up. Journal American Medical Association 2000;281:1707-1713.
5. Bridge JA, Iyengar S, Salary TS et al. Clinical responses and risk for reported suicidal ideation and suicide attempts in paediatric antidepressant treatment: a meta-analysis of randomized controlled trials. Journal American Medical Association 2007;297:1683-1696.
6. Kennard BD, Silva SG, Mayes TL. Assessment of safety and long term outcome of initial treatment with placebo in TADS. American Journal Psychiatry 2009;166:337-344.